Trexquant Investment’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,289
Closed -$2.52M 1857
2025
Q2
$2.52M Buy
+20,289
New +$2.58M 0.03% 808
2024
Q4
Sell
-37,517
Closed -$5.58M 1805
2024
Q3
$5.58M Buy
+37,517
New +$5.38M 0.07% 431
2022
Q4
Sell
-19,491
Closed -$3.65M 1671
2022
Q3
$3.65M Buy
+19,491
New +$4.11M 0.13% 204
2020
Q4
Sell
-8,046
Closed -$1.19M 1413
2020
Q3
$1.19M Sell
8,046
-6,717
-45% -$960K 0.08% 353
2020
Q2
$1.82M Buy
14,763
+3,237
+28% +$381K 0.13% 218
2020
Q1
$1.11M Buy
+11,526
New +$1.11M 0.08% 382
2016
Q2
Sell
-22,172
Closed -$595K 1059
2016
Q1
$595K Buy
22,172
+7,431
+50% +$182K 0.07% 474
2015
Q4
$417K Sell
14,741
-5,575
-27% -$161K 0.04% 744
2015
Q3
$564K Buy
+20,316
New +$734K 0.05% 676
2015
Q2
Sell
-11,200
Closed -$340K 1199
2015
Q1
$340K Sell
11,200
-6,869
-38% -$178K 0.03% 813
2014
Q4
$357K Buy
+18,069
New +$404K 0.06% 611

Other funds holding RGEN

Trexquant Investment's RGEN Position: Q3 2025 in Review

Trexquant Investment sold out of Repligen (RGEN) in Q3 2025, closing a stake of 20,289 shares — an estimated $2.52M sold.

Trexquant Investment first reported a position in RGEN in Q4 2014 and held it in 11 quarters. The position peaked at $5.58M in Q3 2024. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Trexquant Investment reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Trexquant Investment sold 20,289 Repligen shares in Q3 2025, an estimated $2.52M.
  • Trexquant Investment first reported a position in Repligen in Q4 2014 and held it in 11 quarters.
  • Trexquant Investment's Repligen position peaked at $5.58M in Q3 2024.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Trexquant Investment's 13F filing for Q3 2025, filed 14 Nov 2025.